Showing 711-720 of 951 results for "".
Neurostimulation in Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurostimulation-in-drug-resistant-epilepsy/31836/This case illustrates the clinical assessment and process for choosing neurostimulation devices for epilepsy.Headache Disorders: Lifestyle & Behavioral Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-disorders-lifestyle-behavioral-management/31771/Nonmedication treatment may address triggers and symptoms of headache disorders.Moving the Mouse With the Mind
https://practicalneurology.com/diseases-diagnoses/movement-disorders/moving-the-mouse-with-the-mind/30161/Braingate technology allows patients with tetrapalegia to move a computer cursor by thinking about it.Epilepsy Essentials: Epilepsy Genetics: What the General Neurologist Needs To Know
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-epilepsy-genetics-what-the-general-neurologist-needs-to-know/30566/New Diagnostic Tool Approved for Evaluation of Dementia Patients
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/new-diagnostic-tool-approved-for-evaluation-of-dementia-patients/30778/Amyvid, which indicates levels of beta-amyloid plaques in the brain, can help guide the diagnosis of dementia.Dementia Insights:
Short- and Long-Term Cognitive Consequences of Acute Non-Neurological Hospitalizationhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-brshort--and-long-term-cognitive-consequences-of-acute-non-neurological-hospitalization/30786/Most neurologists are not surprised to hear that a patient has cognitively or physically deteriorated after hospitalization, but what is the evidence and mechanism for this?Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.Advancements in MS Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancements-in-ms-therapy/30862/New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.An Update on Nutraceuticals for Migraine Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/Many people with migraine use integrative modalities, including nutraceutical supplements, along with mainstream medicine for disease control.Pharmaceutical Treatment of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pharmaceutical-treatment-of-parkinsons-disease/30242/The best outcomes rely on a handful of medicines and partnership among clinicians, patients, and caregivers.